Centiva Capital’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-12,139	Closed	-$103K	–	1980
2024 Q2	$103K	Buy	+12,139	New	+$103K	﹤0.01%	1377
2022 Q4	–	Sell	-41,300	Closed	-$419K	–	1126
2022 Q3	$419K	Buy	+41,300	New	+$419K	0.01%	550